|
Q3 FY2017
As of Jan 31, 2017
|
Q2 FY2017
As of Oct 31, 2016
|
Q1 FY2017
As of Jul 31, 2016
|
Q4 FY2016
As of Apr 30, 2016
|
Q3 FY2016
As of Jan 31, 2016
|
Q2 FY2016
As of Oct 31, 2015
|
Q1 FY2016
As of Jul 31, 2015
|
Q4 FY2015
As of Apr 30, 2015
|
Q3 FY2015
As of Jan 31, 2015
|
Q2 FY2015
As of Oct 31, 2014
|
Q1 FY2015
As of Jul 31, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| CURRENT ASSETS | |||||||||||
| Cash and cash equivalents | |||||||||||
| Prepayment | |||||||||||
| Accounts receivable | |||||||||||
| Other receivables and other asset | |||||||||||
| Escrow funds receivable | |||||||||||
| Total current assets | |||||||||||
| NON-CURRENT ASSETS | |||||||||||
| Property, plant and equipment, net | |||||||||||
| Prepayment (non-current) | |||||||||||
| Total non-current assets | |||||||||||
| TOTAL ASSETS | |||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
| CURRENT LIABILITIES | |||||||||||
| Accounts payable and accrued liabilities | |||||||||||
| Accounts payable | |||||||||||
| Receipt in advance | |||||||||||
| Other payables | |||||||||||
| Due to shareholder | |||||||||||
| Wages payable | |||||||||||
| Total current liabilities | |||||||||||
| TOTAL LIABILITIES | |||||||||||
| STOCKHOLDERS' EQUITY | |||||||||||
| Common stock, $0.001 par value, 7,000,000,000 and 7,000,000,000 shares authorized; 6,606,065,482 and 4,752,217,304 issued and outstanding as of January 31, 2017 and April 30, 2016, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Stock to be issued | |||||||||||
| Accumulated deficit | |||||||||||
| Subscription receivable | |||||||||||
| Accumulated other comprehensive loss | |||||||||||
| Total stockholders' equity | |||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
